Goeltz II Robert C.

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 79% 68% 82%
Transactions
11 9% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 40%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Goeltz II Robert C.'s trades of Arcus Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-12 2026-05-11
PlS Planned sale
60,931 -7.1%
88.86
US$3,743,875 		60,931 -7.1% 88.86 US$3,743,875
2026-05-11 2026-05-11
PrS Proposed sale
38,167
466.75
US$1,048,441 		38,167 466.75 US$1,048,441
2026-01-02 2025-12-31
PlS Planned sale
55,764 +27.3%
451.04
US$4,940,245 		55,764 +27.3% 451.04 US$4,940,245
2025-12-18 2025-12-17
S Sale
5,960 -7.4%
22.16
US$132,071 		5,960 -7.4% 22.16 US$132,071
2025-12-18 2025-12-16
S Sale
6,702 -7.7%
21.88
US$146,669 		6,702 -7.7% 21.88 US$146,669
2025-12-15 2025-12-16
PrS Proposed sale
14,000
21.90
US$306,600 		14,000 21.90 US$306,600
2025-11-26 2025-11-26
PrS Proposed sale
5,000
25.00
US$125,000 		5,000 25.00 US$125,000
2025-11-26 2025-11-26
PlS Planned sale
5,000 -5.4%
25.00
US$125,000 		5,000 -5.4% 25.00 US$125,000
2025-10-29 2025-10-28
PlS Planned sale
5,000 -5.1%
20.00
US$100,000 		5,000 -5.1% 20.00 US$100,000
2025-10-28 2025-10-28
PrS Proposed sale
5,000
20.00
US$100,000 		5,000 20.00 US$100,000
2025-10-28 2025-10-28
PrS Proposed sale
5,000
20.00
US$100,000 		5,000 20.00 US$100,000
2025-01-03 2024-12-31
PlS Planned sale
3,594 -5.6%
15.00
US$53,910 		3,594 -5.6% 15.00 US$53,910
2024-01-04 2024-01-02
PlS Planned sale
2,004 -3.7%
20.00
US$40,080 		2,004 -3.7% 20.00 US$40,080
2024-01-02 2024-01-02
PrS Proposed sale
2,004
20.00
US$40,080 		2,004 20.00 US$40,080
2023-12-15 2023-12-18
PrS Proposed sale
5,500
17.50
US$96,250 		5,500 17.50 US$96,250
2023-06-09 2023-06-07
PlS Planned sale
4,049 -6.4%
20.04
US$81,142 		4,049 -6.4% 20.04 US$81,142
2023-06-07 2023-06-07
PrS Proposed sale
4,049
20.00
US$80,984 		4,049 20.00 US$80,984
2022-12-16 2022-12-16
S Sale
387 -3.2%
31.23
US$12,086 		387 -3.2% 31.23 US$12,086
2022-12-16 2022-12-16
S Sale
2,066 -14.7%
30.66
US$63,344 		2,066 -14.7% 30.66 US$63,344
2021-12-20 2021-12-17
S Sale
224 -3.1%
41.42
US$9,279 		224 -3.1% 41.42 US$9,279
2021-12-20 2021-12-17
S Sale
171 -2.3%
40.57
US$6,938 		171 -2.3% 40.57 US$6,938
2021-12-20 2021-12-17
S Sale
88 -1.2%
39.67
US$3,491 		88 -1.2% 39.67 US$3,491
2021-12-20 2021-12-17
S Sale
138 -1.8%
38.79
US$5,353 		138 -1.8% 38.79 US$5,353
2021-12-20 2021-12-16
S Sale
131 -1.7%
40.46
US$5,300 		131 -1.7% 40.46 US$5,300
2021-12-20 2021-12-16
S Sale
354 -4.4%
39.59
US$14,015 		354 -4.4% 39.59 US$14,015
2020-09-09 2020-09-09
B Purchase
5,000 +inf%
21.57
US$107,848 		5,000 +inf% 21.57 US$107,848